Autori: Agulnik Jason
| Naslov | Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial (Article) |
| Autori | Hanna Nasser H Kaiser Rolf Sullivan Richard N Aren Osvaldo Rudy Ahn Myung-Ju Tiangco Beatrice Voccia Isabelle von Pawel Joachim Kovcin Vladimir N Agulnik Jason Gaschler-Markefski Birgit Barrueco Jose Sikken Patricia Schloss Charles Kim Joo-Hang |
| Info | LUNG CANCER, (2016), vol. 102 br. , str. 65-73 |
| Projekat | Boehringer Ingelheim |
| Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science Scopus |
     |
